Your hands are mirror images of each other, yet you cannot put a left glove on a right hand. Many molecules behave the same way, and in medicine that difference can decide whether a drug heals or harms. This year’s Nobel Prize in Chemistry honors two researchers who showed how chemists can steer reactions toward just one of the two mirror-image forms.

The announcement

On October 7, the Nobel Assembly at the Karolinska Institute announced that Henri Kagan, of Paris-Sud University, and Kenso Soai, of Tokyo University of Science, share the 2026 Nobel Prize in Chemistry. The citation reads “for the discovery of non-linear effects and autocatalysis in asymmetric organic synthesis.”

Why mirror images matter

Molecules that are non-identical mirror images are called enantiomers, and the property is known as chirality. Life is strongly one-handed: natural amino acids and the sugars in DNA each occur in essentially one form. That means the two mirror versions of a drug can act very differently in the body. The standard cautionary example is thalidomide, whose mirror-image form was linked to severe birth defects in thousands of children in the 1960s. A caveat worth knowing: later research on thalidomide’s chirality is more nuanced than the simple story suggests, so the case is best read as an illustration of the stakes rather than a full explanation.

The idea has deep roots. In 1857, Louis Pasteur let bacteria ferment the two forms of tartaric acid and found they favored only one, an early sign that biological chemistry is chiral. For decades afterward, ordinary lab reactions gave chemists an even 50:50 mix of both forms. Early in the 1900s, Willy Marckwald used a catalyst to tilt the balance very slightly, and later Nobel-winning work built reactions that produced a large excess of one form.

What Kagan and Soai added

Kagan: non-linear effects. Kagan studied the catalysts themselves. In the mid-1980s he reported that using a catalyst made of a mixture of its left- and right-handed forms could, surprisingly, enrich one form of the product more than a simple proportional calculation would predict. This is the “non-linear effect” in the prize citation.

Soai: autocatalysis. In 2003, Soai described a reaction in which the product makes more of itself. A small excess of one handed form was amplified until it made up almost 99.99 percent of the product, according to The Scientist’s summary.

Heiner Linke, chair of the Nobel Committee for Chemistry, called the prize one about foundational chemistry. In his description, Soai’s reaction spontaneously creates only one mirror image, without help from other chiral molecules, which he said had not happened since the processes that gave life its handedness billions of years ago.

Why it matters beyond the lab

The practical payoff is purer products. Understanding how chirality amplifies itself helps chemists optimize reactions to make just the desired form, which is relevant for pharmaceuticals, agricultural chemicals, flavors and scents. Dawn George of CAS, a division of the American Chemical Society, told The Scientist the work gave chemists a stronger foundation for making chiral drug molecules.

One limit to keep in mind: Soai’s reaction is a striking demonstration of the principle, but it is a specific laboratory system.

Sources and further reading